Form 8-K - Current report:
SEC Accession No. 0001641172-25-025336
Filing Date
2025-08-25
Accepted
2025-08-25 07:07:42
Documents
14
Period of Report
2025-08-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 54020
2 EX-3.1 ex3-1.htm EX-3.1 209285
  Complete submission text file 0001641172-25-025336.txt   518107

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hrow-20250821.xsd EX-101.SCH 3943
4 XBRL DEFINITION FILE hrow-20250821_def.xml EX-101.DEF 26961
5 XBRL LABEL FILE hrow-20250821_lab.xml EX-101.LAB 37182
6 XBRL PRESENTATION FILE hrow-20250821_pre.xml EX-101.PRE 25581
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6772
Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 251247877
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)